McGowan Group Asset Management’s Gilead Sciences GILD Stock Holding History

McGowan Group Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,513	Closed	-$204K	–	135
2023 Q4	$204K	Buy	+2,513	New	+$196K	0.03%	128
2023 Q3	–	Sell	-2,727	Closed	-$210K	–	129
2023 Q2	$210K	Buy	2,727 +17	+0.6%	+$1.36K	0.03%	137
2023 Q1	$225K	Buy	2,710 +43	+2%	+$3.56K	0.04%	128
2022 Q4	$229K	Buy	+2,667	New	+$211K	0.04%	127
2016 Q3	–	Sell	-4,624	Closed	-$386K	–	95
2016 Q2	$386K	Hold	4,624	–	–	0.07%	90
2016 Q1	$425K	Sell	4,624 -1,508	-25%	-$136K	0.08%	95
2015 Q4	$620K	Buy	6,132 +14	+0.2%	+$1.46K	0.12%	90
2015 Q3	$601K	Buy	6,118 +642	+12%	+$71.3K	0.12%	93
2015 Q2	$641K	Buy	5,476 +2,391	+78%	+$261K	0.13%	83
2015 Q1	$303K	Buy	+3,085	New	+$313K	0.06%	103

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

McGowan Group Asset Management's GILD Position: Q1 2024 in Review

McGowan Group Asset Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 2,513 shares — an estimated $204K sold.

McGowan Group Asset Management first reported a position in GILD in Q1 2015 and held it in 10 quarters. The position peaked at $641K in Q2 2015. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

McGowan Group Asset Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
McGowan Group Asset Management sold 2,513 Gilead Sciences shares in Q1 2024, an estimated $204K.
McGowan Group Asset Management first reported a position in Gilead Sciences in Q1 2015 and held it in 10 quarters.
McGowan Group Asset Management's Gilead Sciences position peaked at $641K in Q2 2015.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on McGowan Group Asset Management's 13F filing for Q1 2024, filed 15 May 2024.